Rep. Ami Bera

Maddy summaryThe WEAR IT Act (HR 6279) allows individuals to use funds from tax-advantaged health savings accounts (HSAs), Archer MSAs, and flexible spending accounts (FSAs) to cover the cost of medical wearable devices, up to $375 annually. It defines "wearable devices" as body-worn tools that collect physiological data for diagnosing, treating, or preventing disease. The bill amends tax code provisions to include these devices as qualified medical expenses, effective for purchases after December 31, 2023. This directly affects people using medical wearables who rely on tax-advantaged health accounts for out-of-pocket costs.

Maddy summaryThis bill creates a federal program to reimburse health care providers for treating uninsured patients with rabies postexposure prophylaxis (rabies treatment), requiring providers to accept the reimbursement and not bill patients for the service. It also mandates that private insurance plans and Medicare cover rabies treatment with no out-of-pocket costs (100% coverage, no deductibles) for insured individuals. Additionally, the bill provides grants to local health departments to stockpile rabies treatment supplies for rapid response. The law directly affects uninsured patients facing high treatment costs, health care providers, and local health departments managing emergency supplies.

Maddy summaryThis bill requires health insurance plans (both private and Medicare) to cover routine patient costs for children with rare pediatric diseases participating in approved clinical trials, even when care is provided by non-network providers. Specifically, it mandates that insurers apply the same copay or coinsurance rate for non-participating providers as they would for in-network providers during clinical trial participation. The law expands the definition of "routine costs" to include consultation and referral services related to these trials and updates Medicare coverage rules to align with this requirement. These changes apply to plans beginning January 1, 2024, directly affecting families of children with rare pediatric cancers enrolled in qualifying clinical trials.

Maddy summaryThis bill imposes U.S. sanctions on foreign individuals and entities that facilitate North Korea's transfer of arms or material support to Russia for use in Russia's invasion of Ukraine. It targets those responsible for such transfers, including foreign financial institutions enabling significant transactions related to these activities, requiring property blocks and visa restrictions. The bill also amends existing North Korea sanctions to explicitly require halting such material support and mandates the President to submit regular reports to Congress on North Korea's involvement and U.S. strategies to counter it.

Maddy summaryThe Preserving Access to Home Health Act of 2023 repeals a 2018 payment adjustment for Medicare home health agencies, restoring prior payment rates for 2024 and subsequent years. It requires the Medicare Payment Advisory Commission (MedPAC) to analyze how home health agencies' financial performance affects access to care, including reviewing spending and utilization data across Medicare, Medicaid, and other payers. Starting in 2025, the bill mandates home health agencies to report detailed data on visit volumes and payments by payer source (Medicare, Medicaid, private insurers) through updated cost reports. This data will help MedPAC assess payment policy impacts on access to home health services for Medicare beneficiaries.

Maddy summaryThis bill simplifies participation in Medicare's Accountable Care Organization (ACO) program by removing distinctions between small and large ACOs and eliminating the requirement for new ACOs to assume financial risk for three years before joining shared savings models. It creates a new "100% shared savings" option where ACOs keep all savings from cost reductions but bear full financial responsibility for losses. The bill also mandates clearer, transparent benchmark calculations for ACO performance, establishes appeal processes for disputed benchmarks, and requires technical assistance for rural and underserved providers. These changes directly affect Medicare ACOs, particularly smaller or newer organizations in rural or safety-net settings, aiming to make value-based care participation more accessible.

Maddy summaryThe Social Security 2100 Act would significantly enhance Social Security benefits for millions of Americans by increasing monthly payments for retirees, disabled workers, widows/widowers, and children. Key provisions include raising the minimum benefit for long-term low earners, improving cost-of-living adjustments using a more accurate index, eliminating the 5-month waiting period for disability benefits, and extending child benefits to age 26. The bill also changes how Social Security taxes are calculated by applying them to income above $400,000 and establishes a unified Social Security Trust Fund to manage program finances. Most provisions would apply to benefits payable from 2025 through 2034, affecting all current and future Social Security beneficiaries.

Maddy summaryThe BLUE Pacific Act establishes a comprehensive U.S. strategy to deepen engagement with Pacific Island nations through coordinated assistance across multiple policy areas. It authorizes $250 million annually for fiscal years 2023-2033 to support initiatives in climate resilience, economic development, security capacity building, public health, and democratic governance. The act requires the President to develop a Pacific Islands Partnership Strategy by 2027, with regular congressional reporting, and mandates consultation with Pacific Island nations and regional organizations. This legislation formalizes U.S. efforts to support Pacific Island countries in addressing shared challenges like climate change, economic development, and security while strengthening regional partnerships. The strategy will guide U.S. assistance across multiple agencies to support Pacific Island nations' priorities as outlined in regional frameworks like the 2050 Strategy for the Blue Pacific Continent.

Maddy summaryHR 4402 clarifies transparency reporting requirements for pharmaceutical manufacturers. It adds specific educational materials - like peer-reviewed journals, journal reprints, medical conference reports, and textbooks - to the list of items manufacturers must report when transferring value to healthcare providers. This change directly affects drug manufacturers who provide these educational resources to doctors or institutions. The bill expands existing reporting rules under the Social Security Act to ensure greater transparency about such transfers. The amendment applies to transfers made on or after the law's enactment date.

Maddy summaryThis bill expands Medicare coverage to include home infusion treatment for people with Alpha-1 Antitrypsin Deficiency Disorder, a genetic condition causing lung and liver damage. It specifically covers "augmentation therapy" (a standard treatment using Alpha-1 Proteinase Inhibitor) when administered in a patient's home by qualified providers. Medicare will pay 80% of the cost for intravenous kits and up to 2 hours of nursing care during these home infusions, starting January 1, 2025. The change directly affects Medicare beneficiaries with this condition who require home-based treatment and their qualified home infusion providers.